Bausch Health Ireland Limited et al v. Mylan Pharmaceuticals Inc.
| Bausch Health Ireland Limited and Salix Pharmaceuticals, Inc. |
| Mylan Pharmaceuticals Inc. |
| 1:2024cv00036 |
| April 5, 2024 |
| US District Court for the Northern District of West Virginia |
| Thomas S Kleeh |
| Patent - Abbreviated New Drug Applications (ANDA) |
| 35 U.S.C. ยง 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on April 5, 2024. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 2 SUPPLEMENTAL INFORMATION FOR PATENT CASES INVOLVING AN ABBREVIATED NEW DRUG APPLICATION (ANDA) filed by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc. (dk) |
| Filing 1 COMPLAINT against Mylan Pharmaceuticals Inc., filed by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc. Filing Fee PAID $405. Receipt #AWVNDC-3918801. (Attachments: #1 US Patent 11,834,521 B2, #2 Civil Cover Sheet, #3 Supplement to Civil Cover Sheet) (dk) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
